E protein silencing by the leukemogenic AML1-ETO fusion protein

Science

Volumn 305, Issue 5688, 2004, Pages 1286-1289

  Zhang, Jinsong ^a   Kalkum, Markus ^a   Yamamura, Soichiro ^a   Chait, Brian T ^a   Roeder, Robert G ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; CHROMOSOMES; ENZYME INHIBITION; TUMORS;

ACUTE MYELOID LEUKEMIA (AML); CHROMOSOMAL TRANSLOCATION; FUSION PROTEIN; HOMOLOGY DOMAIN;

PROTEINS;

AMINO ACID; CCAAT ENHANCER BINDING PROTEIN; CELL PROTEIN; E PROTEIN; HYBRID PROTEIN; PROTEIN AML1 ETO; PROTEIN ETO; PROTEIN P300; TRANSCRIPTION FACTOR RUNX1; UNCLASSIFIED DRUG;

BIOLOGY; PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME TRANSLOCATION; GENE SILENCING; HUMAN; LEUKEMIA CELL; LEUKEMOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION INITIATION;

ACUTE DISEASE; AMINO ACID SEQUENCE; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL LINE; CELL LINE, TUMOR; CONSERVED SEQUENCE; CORE BINDING FACTOR ALPHA 2 SUBUNIT; CREB-BINDING PROTEIN; DNA-BINDING PROTEINS; GENE SILENCING; HELA CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; JURKAT CELLS; LEUKEMIA, MYELOID; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; ONCOGENE PROTEINS, FUSION; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSLOCATION, GENETIC;

EID: 4344669438     PISSN: 00368075     EISSN: None     Source Type: Journal    
DOI: 10.1126/science.1097937     Document Type: Article

References (25)

1. J. D. Licht, Oncogene 20, 5660 (2001).
2. J. M. Scandura, P. Boccuni, J. Cammenga, S. D. Nimer, Oncogene 21, 3422 (2002).
3. B. A. Hug, M. A. Lazar, Oncogene 23, 4270 (2004).
4. I. Kitabayashi et al., Mol. Cell. Biol. 18, 846 (1998).
5. M. W. Quong, W. J. Romanow, C. Murre, Annu. Rev. Immunol. 20, 301 (2002).
6. M. E. Massari, C. Murre, Mol. Cell. Biol. 20, 429 (2000).
7. J. Zhang, R. G. Roeder, unpublished data.
8. A. B. Lassar et al., Cell 66, 305 (1991).
9. D. M. Heery, E. Kalkhoven, S. Hoare, M. G. Parker, Nature 387, 733 (1997).
10. H. Miyoshi et al., EMBO J. 12, 2715 (1993).
11. F. Calabi, R. Pannell, G. Pavloska. Mol. Cell. Biol. 21, 5658 (2001).
12. I. Engel, C. Murre, EMBO J. 23, 202 (2004).
13. M. B. Ruzinova, R. Benezra, Trends Cell Biol. 13, 410 (2003).
14. M. Markus, Z. Du, R. Benezra, J. Biol. Chem. 277, 6469 (2002).
15. I. Engel, C. Murre, Proc. Natl. Acad. Sci. U.S.A. 96, 996 (1999).
16. A. Pagliuca, P. Gallo, P. De Luca, L. Lania, Cancer Res. 60, 1376 (2000).
17. J. S. Hu, E. N. Olson, R. E. Kingston, Mol. Cell. Biol. 12, 1031 (1992).
18. H. Sjogren et al., Cancer Res. 60, 6832 (2000)
19. T. Okuda et al., Blood 91, 3134 (1998).
20. B. A. Hug, S. Y. Lee, E. L. Kinsler, J. Zhang, M. A. Lazar, Cancer Res. 62, 2906 (2002).
21. J. C. Mulloy et al., Blood 99, 15 (2002).
22. C. G. de Guzman et al., Mol. Cell. Biol. 22, 5506 (2002).
23. M. Schwieger et al., J. Exp. Med. 195, 1227 (2002).
24. K. L. Rhoades et al., Blood 96, 2108 (2000).
25. Acknowledgements are presented in the supporting online material.. Molecular interaction data have been deposited in the Biomolecular Interaction Network Database with accession codes 150973, 150974, 150975, 150976, 150977, 150978, 150979, 150980, 150981, 150982, 150983, 150984, 150985, 150986, 150987, 150988, 150989, 150990, 150991, 150992, and 150993.